Eltrombopag for the Treatment of Immune ThrombocytoPenia (ITP) Secondary to Chronic Lymphoproliferative Disorders (LPDs)

NCT01610180 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

18

Enrollment

OTHER

Sponsor class

Conditions

Purpura, Thrombocytopenic, Idiopathic
Autoimmune Thrombocytopenic Purpura
Autoimmune Thrombocytopenia
Chronic Lymphocytic Leukemia
Non Hodgkin's Lymphoma

Interventions

DRUG: Eltrombopag Olamine

Sponsor

Fondazione Progetto Ematologia